...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies

 

 
 
 
Julien Potet
 
@julienpotet
 
Good news. 129 moderate or severe patients w/ #COVID19. 65 in #tocilizumab arm, 64 in control arm. Endpoint: death or need for mechanical ventilation by D14. Tocilizumab signficantly superior to control arm. Publication will follow soon 1/2
Share
New Message
Please login to post a reply